Literature DB >> 18256220

Differential mucoid exopolysaccharide production by members of the Burkholderia cepacia complex.

James E A Zlosnik1, Trevor J Hird, Monica C Fraenkel, Leonilde M Moreira, Deborah A Henry, David P Speert.   

Abstract

We demonstrate that all nine species of the Burkholderia cepacia complex can express the mucoid phenotype. A survey of clinical isolates showed that strains of B. cenocepacia, the most virulent species of the complex, are most frequently nonmucoid. Additionally, isolates from patients with chronic infections can convert from mucoid to nonmucoid.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18256220      PMCID： PMC2292898          DOI： 10.1128/JCM.02273-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

1.  Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex.

Authors:  E Mahenthiralingam; T Coenye; J W Chung; D P Speert; J R Govan; P Taylor; P Vandamme
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Enzymes leading to the nucleotide sugar precursors for exopolysaccharide synthesis in Burkholderia cepacia.

Authors:  J A Richau; J H Leitão; I Sá-Correia
Journal:  Biochem Biophys Res Commun       Date:  2000-09-16       Impact factor: 3.575

3.  Updated version of the Burkholderia cepacia complex experimental strain panel.

Authors:  Tom Coenye; Peter Vandamme; John J LiPuma; John R W Govan; Eshwar Mahenthiralingam
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

4.  Determinants of mortality from cystic fibrosis in Canada, 1970-1989.

Authors:  M Corey; V Farewell
Journal:  Am J Epidemiol       Date:  1996-05-15       Impact factor: 4.897

5.  Exopolysaccharides produced by clinical strains belonging to the Burkholderia cepacia complex.

Authors:  Yury Herasimenka; Paola Cescutti; Giuseppe Impallomeni; Silvia Campana; Giovanni Taccetti; Novella Ravenni; Flavio Zanetti; Roberto Rizzo
Journal:  J Cyst Fibros       Date:  2006-07-21       Impact factor: 5.482

6.  Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.

Authors:  A Isles; I Maclusky; M Corey; R Gold; C Prober; P Fleming; H Levison
Journal:  J Pediatr       Date:  1984-02       Impact factor: 4.406

7.  Studies on the involvement of the exopolysaccharide produced by cystic fibrosis-associated isolates of the Burkholderia cepacia complex in biofilm formation and in persistence of respiratory infections.

Authors:  Mónica V Cunha; Sílvia A Sousa; Jorge H Leitão; Leonilde M Moreira; Paula A Videira; Isabel Sá-Correia
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

8.  Production of exopolysaccharide by Burkholderia cenocepacia results in altered cell-surface interactions and altered bacterial clearance in mice.

Authors:  Barbara-Ann D Conway; Karen K Chu; Johan Bylund; Eleonora Altman; David P Speert
Journal:  J Infect Dis       Date:  2004-07-26       Impact factor: 5.226

9.  Identification and physical organization of the gene cluster involved in the biosynthesis of Burkholderia cepacia complex exopolysaccharide.

Authors:  Leonilde M Moreira; Paula A Videira; Sílvia A Sousa; Jorge H Leitão; Mónica V Cunha; Isabel Sá-Correia
Journal:  Biochem Biophys Res Commun       Date:  2003-12-12       Impact factor: 3.575

10.  Colonial morphology of Burkholderia cepacia complex genomovar III: implications in exopolysaccharide production, pilus expression, and persistence in the mouse.

Authors:  Jacqueline W Chung; Eleonora Altman; Terry J Beveridge; David P Speert
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441
View more
  38 in total

Review 1.  A decade of Burkholderia cenocepacia virulence determinant research.

Authors:  Slade A Loutet; Miguel A Valvano
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

Review 2.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

3.  Regulator LdhR and d-Lactate Dehydrogenase LdhA of Burkholderia multivorans Play Roles in Carbon Overflow and in Planktonic Cellular Aggregate Formation.

Authors:  Inês N Silva; Marcelo J Ramires; Lisa A Azevedo; Ana R Guerreiro; Andreia C Tavares; Jörg D Becker; Leonilde M Moreira
Journal:  Appl Environ Microbiol       Date:  2017-09-15       Impact factor: 4.792

4.  Comparative transcriptomic analysis of the Burkholderia cepacia tyrosine kinase bceF mutant reveals a role in tolerance to stress, biofilm formation, and virulence.

Authors:  Ana S Ferreira; Inês N Silva; Vítor H Oliveira; Jörg D Becker; Michael Givskov; Robert P Ryan; Fábio Fernandes; Leonilde M Moreira
Journal:  Appl Environ Microbiol       Date:  2013-02-22       Impact factor: 4.792

5.  Burkholderia cenocepacia virulence microevolution in the CF lung: Variations on a theme.

Authors:  Jonathan J Dennis
Journal:  Virulence       Date:  2016-10-27       Impact factor: 5.882

6.  Commonalities and differences in regulation of N-acyl homoserine lactone quorum sensing in the beneficial plant-associated burkholderia species cluster.

Authors:  Zulma Rocío Suárez-Moreno; Giulia Devescovi; Mike Myers; Letícia Hallack; Lucia Mendonça-Previato; Jesús Caballero-Mellado; Vittorio Venturi
Journal:  Appl Environ Microbiol       Date:  2010-04-30       Impact factor: 4.792

Review 7.  The art of persistence-the secrets to Burkholderia chronic infections.

Authors:  Eric R G Lewis; Alfredo G Torres
Journal:  Pathog Dis       Date:  2016-07-19       Impact factor: 3.166

8.  Distribution of cepacian biosynthesis genes among environmental and clinical Burkholderia strains and role of cepacian exopolysaccharide in resistance to stress conditions.

Authors:  Ana S Ferreira; Jorge H Leitão; Inês N Silva; Pedro F Pinheiro; Sílvia A Sousa; Christian G Ramos; Leonilde M Moreira
Journal:  Appl Environ Microbiol       Date:  2009-11-30       Impact factor: 4.792

9.  Variation of Burkholderia cenocepacia virulence potential during cystic fibrosis chronic lung infection.

Authors:  Ana S Moreira; Dalila Mil-Homens; Sílvia A Sousa; Carla P Coutinho; Ana Pinto-de-Oliveira; Christian G Ramos; Sandra C Dos Santos; Arsénio M Fialho; Jorge H Leitão; Isabel Sá-Correia
Journal:  Virulence       Date:  2016-09-21       Impact factor: 5.882

10.  Identification of potential therapeutic targets for Burkholderia cenocepacia by comparative transcriptomics.

Authors:  Deborah R Yoder-Himes; Konstantinos T Konstantinidis; James M Tiedje
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.